$9.080
-0.252 (-2.78%)Al cierre
Comparativa sectorial de MSLE
In the context of the broader market, MSLE competes directly with industry leaders such as ELDN and NMRA. With a market capitalization of $198.16M, it holds a significant position in the sector. When comparing efficiency, MSLE's gross margin of N/A stands against ELDN's N/A and NMRA's N/A. Such benchmarking helps identify whether Satellos Bioscience Inc. is trading at a premium or discount relative to its financial performance.
Desempeño financiero de Satellos Bioscience Inc
Satellos has been experiencing significant net losses, with the latest reported net income of -11,718,000 USD for Q2 2026. The company has a current ratio of 11.22, indicating strong liquidity, but the overall financial health is challenged by ongoing losses.
Financials
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.